Ergebnis der Suchanfrage nach d&uuml

Europäischer Rechnungshof - European Court of Auditors

NVO skiriamas ES finansavimas yra pernelyg neskaidrus, teigia auditoriai

Immunity Pharma

Immunity Pharma Presents New Data Supporting the Efficacy of IPL344 in ALS

Jerusalem (ots/PRNewswire) - - Results from phase 2a trial in ALS patients were published in Muscle and Nerve. - Statistically significant 58% to 64% slower ALSFRS-R progression rate in IPL344-treated patients compared to the matched PRO-ACT records. - NfL was reduced by 27% for patients treated for at least two months. - Unadjusted median survival for participants in ...

Munich Electrification GmbH

Munich Electrification joins EES EUROPE 2025

Weleda AG

Financial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability

Europäischer Rechnungshof - European Court of Auditors

(Spaudos konferencija) NVO skiriamas ES finansavimas – ar jis tikrai skaidrus?

Kvietimas žiniasklaidai 2025 m. balandžio 7 d NVO skiriamas ES finansavimas – ar jis tikrai skaidrus? - Virtuali spaudos konferencija: balandžio 7 d. (pirmadienį) 11.00 val. CEST - Ataskaitos paskelbimas: tą pačią dieną 17.00 val. CEST 2025 m. balandžio 7 d. ...

Infineon Technologies AG

Infineon strengthens its position as innovation driver in the semiconductor industry in India with new R&D hub

Hellmann Worldwide Logistics

2

Hellmann: Protecting wetlands is an important lever for climate protection

nova-Institut GmbH

3

“Best CO₂ Utilisation 2025”: Celebrating Pioneering Innovation in Carbon Capture and Utilisation Technologies

nova-Institut GmbH

5

Advanced Recycling Conference 2025 – Shaping the Future of the Circular Economy

STADA Arzneimittel AG

3

Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market

Infineon Technologies AG

Infineon and Automotive Research Association of India collaborate to advance automotive semiconductor solutions

Helmholtz Munich

New Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized Data

Marc Cain GmbH

Marc Cain Hosted an Exclusive Pop-Up Store During New York Fashion Week

nova-Institut GmbH

6

CO₂ Revolution 2025: Fueling the Future, Capturing Possibilities

Hellmann Worldwide Logistics

Hellmann: Lee I´Ons appointed new Regional CEO IMEA

UPLINK Network GmbH

Uplink Group acquires BOS-Funk operator ConnectCom in Luxembourg

DYMO Deutschland

DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS

Hellmann Worldwide Logistics

Hellmann appoints Gilles Duffaut as new Managing Director France

Helmholtz Munich

Ancient Viral DNA Shapes Early Embryo Development

Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...

Helmholtz Munich

SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues

Bosch Healthcare Solutions GmbH

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Norgine GmbH

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

nova-Institut GmbH

6

Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025